Publication & Citation Trends
Publications
132 total
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary. OA
Cited by 2
Semantic Scholar
External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices OA
Cited by 0
Semantic Scholar
Clinical development of antibody-drug conjugates in triple negative breast cancer: can we jump higher?
Cited by 6
Semantic Scholar
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma PDF
Cited by 1,003
OpenAlex
First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC).
Cited by 43
Semantic Scholar
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group OA
Cited by 3
Semantic Scholar
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group OA
Cited by 17
Semantic Scholar
133TiP A phase II trial of nivolumab + palbociclib + anastrozole in postmenopausal women with ER+/HER2– primary breast cancer: CheckMate 7A8 OA
Cited by 3
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(55)
Breast Cancer Treatment Studies
(52)
Advanced Breast Cancer Therapies
(50)
Cancer Genomics and Diagnostics
(23)
Cancer Treatment and Pharmacology
(22)
Affiliations
Université Paris-Sud
Roche (Switzerland)
Indiana University Health
Novartis (Switzerland)
Université Libre de Bruxelles